A New Era in Child Healthcare: Eli Lilly and UNICEF Forge Landmark Global Alliance
Eli Lilly and Company and UNICEF have announced a landmark global partnership aimed at improving healthcare access and disease prevention for millions of children...
Dr. Reddy’s and Nestlé Health Science Strengthen Partnership with Launch of Celevida GLP+ to Support Diabetes and Weight Management
Dr. Reddy’s and Nestlé Health Science Ltd. announced a strategic expansion in the diabetes and obesity sector with the launch of Celevida GLP+. This specialized, science-backed nutritional...
Cipla Revolutionizes Respiratory Care with Launch of Ciposcillo®️, India’s First Next-Gen Tidal-Breathing Diagnostic Device
Cipla Limited (announced the launch of Ciposcillo®, a next-generation oscillometer designed for the precise assessment of respiratory mechanics. This advanced device is engineered to provide early...
Zydus Fast-Tracks Malaria Fight: DCGI Greenlights Phase III Trials for Breakthrough Drug Zintrodiazine
Zydus Lifesciences Limited (“Zydus”), a leading innovation-driven global lifesciences company, has received regulatory approval from the Drugs Controller General of India (DCGI) to commence two Phase...
Lupin Limited Secures U.S. FDA Nod for Glycerol Phenylbutyrate Oral Liquid in Urea Cycle Disorders
Lupin has announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application...
New Meta-Analysis Ranks CAPLYTA®️ Lumateperone First in Efficacy and Metabolic Safety for Adjunctive MDD Treatment
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...